封面
市场调查报告书
商品编码
1373859

全球静脉曲张治疗市场 - 市场规模、份额、成长分析:按类型、最终用途 - 产业预测(2023-2030)

Global Varicose Veins Treatment Market Size, Share, Growth Analysis, By Type(Endovenous Ablation, and Surgical Ligation & Stripping), By End-use(Vein clinics, hospitals) - Industry Forecast 2023-2030

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计2021年全球静脉曲张治疗市场规模为12.2亿美元,2022年为13亿美元。预计在预测期(2023-2030年),市场将以6.32%的年复合成长率扩张,到2030年将达到21.2亿美元。

全球静脉曲张治疗市场近年来取得了显着成长,预计未来将继续扩大。静脉曲张是一种常见的疾病,其特征是静脉肿胀和扭曲,主要发生在腿部。人口高龄化、久坐的生活方式、肥胖和遗传因素等因素导致全球静脉曲张盛行率不断上升,推动了对有效治疗方案的需求。市面上有多种治疗方法,包括内源性雷射消融、硬化疗法和射频消融等微创手术。与传统手术方法相比,这些手术具有减轻疼痛、加速恢復时间和最小化疤痕等优点。微创治疗的日益普及正在推动静脉曲张治疗市场的成长。此外,技术和医疗设备的进步正在进一步改善治疗结果和患者满意度。超音波导引泡沫硬化疗法和非热消融等创新技术在有效治疗静脉曲张方面显示出良好的效果。这些进步不仅扩大了可用的治疗选择,而且改善了患者的整体体验。然而,儘管市场成长潜力巨大,但也存在一些挑战。报销问题和高昂的治疗费用可能会限制某些患者获得静脉曲张治疗。保险覆盖范围和报销政策不足可能会造成经济障碍,尤其是在新兴经济体。

关于静脉曲张和可用治疗方案的意识和教育的不断提高正在促进市场的成长。公众宣传活动、患者教育活动以及透过各种管道普及资讯鼓励静脉曲张患者接受适当的治疗。

积极的报销政策,特别是在已开发国家,促进了患者获得静脉曲张治疗。对硬化疗法和静脉消融等手术的保险范围和报销支持使这些治疗方法变得更实惠和容易获得,从而推动了市场成长。

该报告研究了全球静脉曲张治疗市场,并提供了市场概述,包括按类型、最终用途、地区和参与市场的公司概况分類的趋势。

目录

执行摘要

母市场分析

市场规模

  • 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务

关键市场洞察

  • 技术分析
  • 价格分析
  • 供应链分析
  • 价值链分析
  • 市场生态系统
  • 智慧财产权分析
  • 趋势分析
  • 启动分析
  • 原料分析
  • 创新矩阵
  • 研发线产品分析
  • 总体经济指标
  • 顶级投资分析
  • 关键成功因素
  • 竞争程度

市场动态及展望

  • 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
  • 法规状况
  • 波特分析

按类型分類的全球静脉曲张治疗市场

  • 市场概况
  • 静脉消融
  • 手术结扎、剥离

全球静脉曲张治疗市场(依最终用途)

  • 市场概况
  • 静脉诊所
  • 医院
  • 和门诊治疗设施。

全球静脉曲张治疗市场(按地区)

  • 市场概况
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

竞争形势

  • 主要企业简介
    • Medtronic
    • AngioDynamics
    • Lumenis
    • Syneron Medical Ltd.
    • Biolitec AG
    • BTG International Ltd
    • Vascular Solutions, Inc.
    • Energist Group
    • Eufoton
    • Quanta System
    • Miravas
    • Vein Clinics of America
    • Alna-Medical System GmbH
    • Miravas SAS
    • Sciton, Inc.
    • Dornier MedTech GmbH
    • LSO Medical
    • Vascular Insights, LLC
    • WONTECH Co., Ltd.
    • LSO Medical SAS
简介目录
Product Code: SQMIG35E2025

Global Varicose Veins Treatment Market size was valued at USD 1.22 Billion in 2021 and is poised to grow from USD 1.3 Billion in 2022 to USD 2.12 Billion by 2030, at a CAGR of 6.32% during the forecast period (2023-2030).

The global varicose veins treatment market has experienced significant growth in recent years and is expected to continue expanding in the coming years. Varicose veins are a common medical condition characterized by swollen and twisted veins, primarily in the legs. Factors such as aging population, sedentary lifestyles, obesity, and hereditary factors contribute to the rising prevalence of varicose veins worldwide, driving the demand for effective treatment options. Several treatment modalities are available in the market, including minimally invasive procedures such as endogenous laser ablation, sclerotherapy, and radiofrequency ablation. These procedures offer advantages such as reduced pain, shorter recovery time, and minimal scarring compared to traditional surgical methods. The increasing adoption of minimally invasive treatments is fueling the growth of the varicose veins treatment market. Moreover, advancements in technology and medical devices have further improved treatment outcomes and patient satisfaction. Innovative techniques, such as ultrasound-guided foam sclerotherapy and non-thermal ablation, have shown promising results in effectively treating varicose veins. These advancements have not only expanded the treatment options available but also enhanced the overall patient experience. However, despite the market's growth potential, several challenges exist. Reimbursement issues and the high cost of treatment can limit the accessibility of varicose veins treatment for some patients. Inadequate insurance coverage and reimbursement policies may pose financial barriers, particularly in developing countries.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Varicose Veins Treatment Market Segmental Analysis

The global varicose veins treatment market is segmented on the basis of type, end-use, and region. By type, the market is segmented into Endovenous Ablation, and Surgical Ligation & Stripping. By end use, the market is segmented into vein clinics, hospitals, and ambulatory care units. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Varicose Veins Treatment Market Dynamics

Drivers of the Global Varicose Veins Treatment Market

Growing Awareness and Patient Education

Increased awareness and education regarding varicose veins and available treatment options have contributed to market growth. Public awareness campaigns, patient education initiatives, and information dissemination through various channels have encouraged individuals with varicose veins to seek appropriate treatment.

Favorable Reimbursement Policies

Positive reimbursement policies, particularly in developed countries, have facilitated access to varicose veins treatment for patients. Insurance coverage and reimbursement support for procedures like sclerotherapy and endovenous ablation have made these treatments more affordable and accessible, boosting market growth.

Restraints in the Global Varicose Veins Treatment Market

Regulatory Challenges

Regulatory requirements and product approval processes can pose challenges for manufacturers in the varicose veins treatment market. Obtaining regulatory approvals and complying with various regulations in different countries can be time-consuming and costly, affecting the introduction of new treatments and innovations.

Alternative Treatment Options

Alternative treatments, such as compression therapy and lifestyle modifications, may be considered by some patients as an initial or complementary approach to managing varicose veins. These non-invasive options can compete with more invasive treatment methods, potentially impacting the market growth of varicose veins treatments.

Market Trends of the Global Varicose Veins Treatment Key

Growing Emphasis on Combination Therapies

Combination therapies involving multiple treatment modalities are gaining popularity in varicose veins treatment. Combining procedures such as endovenous ablation and sclerotherapy can optimize outcomes by targeting different aspects of the venous disease, leading to improved efficacy and patient satisfaction.

Focus on Patient-Centric Approaches

There is an increasing emphasis on patient-centric care in varicose veins treatment. Healthcare providers are focusing on personalized treatment plans, patient education, and shared decision-making to ensure optimal outcomes and patient satisfaction.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Varicose Veins Treatment Market by Type
    • Market Overview
    • Endovenous Ablation
    • and Surgical Ligation & Stripping
  • Global Varicose Veins Treatment Market by End-use
    • Market Overview
    • Vein clinics
    • hospitals
    • and ambulatory care units
  • Global Varicose Veins Treatment Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • AngioDynamics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Lumenis (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Syneron Medical Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Biolitec AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • BTG International Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Vascular Solutions, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Energist Group (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Eufoton (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Quanta System (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Miravas (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Vein Clinics of America (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Alna-Medical System GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Miravas SAS (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Sciton, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Dornier MedTech GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • LSO Medical (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Vascular Insights, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • WONTECH Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • LSO Medical SAS (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments